Brief: Beacon Biosignals Raises $86 Million to Accelerate AI-Driven Insights into Brain Health
Nov 13 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T: BEACON BIOSIGNALS RAISES $86M TO ACCELERATE AI-DRIVEN INSIGHTS INTO BRAIN HEALTH BEACON BIOSIGNALS: FUNDING ROUND BACKED BY INNOVIVA, GOOGLE VENTURES, NEXUS NEUROTECH VENTURES, S32, TAKEDA & OTHERS Source text: nGNX15DxVz Further company coverage: 4502.T ((reuters.briefs@thomsonreuters.com;))
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)